Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy

OBJECTIVE: Erythropoietin (Epo) is neuroprotective in animal models of neonatal hypoxic-ischemic encephalopathy. We previously reported a phase I safety and pharmacokinetic study of Epo in neonates. This paper presents the neurodevelopmental follow-up of infants who were enrolled in the phase I clin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Neurol
Autors principals: Rogers, Elizabeth E., Bonifacio, Sonia L., Glass, Hannah C., Juul, Sandra E., Chang, Taeun, Mayock, Dennis E., Durand, David J., Song, Dongli, Barkovich, Anthony J., Ballard, Roberta A., Wu, Yvonne W.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402201/
https://ncbi.nlm.nih.gov/pubmed/25439577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2014.08.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars